QRxPharma Ltd:企業の戦略的SWOT分析

◆英語タイトル:QRxPharma Ltd - Strategic SWOT Analysis Review
◆商品コード:GDPH138339SA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥50,625見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

QRxPharma Ltd – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

QRxPharma Ltd (QRxPharma) develops and commercializes treatments for pain management and abuse prevention products. The company’s product portfolio includes late and early stage clinical drug candidates. QRxPharma’s dual opioid product portfolio includes Moxduo IR (Q8003), an immediate release oral capsule for the treatment of acute management of moderate to severe pain; Moxduo IV (Q8012), an intravenous formulation for moderate to severe hospital-based pain; and Moxduo CR (Q8011), a controlled release oral tablet being developed in Phase II clinical trial for the treatment of chronic pain. The company’s abuse deterrent technology called Stealth Beadlets has been developed for controlled release Moxduo formulation. It has operations in the US and Australia. QRxPharma is headquartered in North Sydney, New South Wales, Australia.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
List of Tables
Section 1 – About the Company
QRxPharma Ltd – Key Facts
QRxPharma Ltd – Key Employees
QRxPharma Ltd – Major Products and Services
QRxPharma Ltd – History
QRxPharma Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
QRxPharma Ltd – Business Description
QRxPharma Ltd – Corporate Strategy
QRxPharma Ltd – SWOT Analysis
SWOT Analysis – Overview
QRxPharma Ltd – Strengths
QRxPharma Ltd – Weaknesses
QRxPharma Ltd – Opportunities
QRxPharma Ltd – Threats
QRxPharma Ltd – Key Competitors
Section 3 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
QRxPharma Ltd, Key Facts
QRxPharma Ltd, Key Employees
QRxPharma Ltd, Major Products and Services
QRxPharma Ltd, History
QRxPharma Ltd, Subsidiaries
QRxPharma Ltd, Joint Venture
QRxPharma Ltd, Key Competitors

★海外企業調査レポート[QRxPharma Ltd:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Natural Capsules Ltd (524654):企業の財務・戦略的SWOT分析
    Natural Capsules Ltd (524654) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Univision Communications Inc.:企業の戦略・SWOT・財務分析
    Univision Communications Inc. - Strategy, SWOT and Corporate Finance Report Summary Univision Communications Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Clay Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Clay Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Soleno Therapeutics Inc (SLNO):医療機器:M&Aディール及び事業提携情報
    Summary Soleno Therapeutics Inc (Soleno), formerly Capnia Inc is a medical equipment company that designs, develops and commercializes novel therapeutic and diagnostic products. The company provides products such as serenz, cosense, and others. It offers serenz which is a hand-held device, which is …
  • Cardiovascular Systems Inc (CSII):企業の財務・戦略的SWOT分析
    Summary Cardiovascular Systems Inc (CSI) is a medical device company that develops and commercializes products for the treatment of peripheral and coronary vascular disease. The company's products include peripheral orbital atherectomy system, coronary orbital atherectomy system, crowns, and accesso …
  • Oncternal Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Oncternal Therapeutics Inc (Oncternal), formerly Tokalas, Inc., is a clinical-stage oncology company which focuses on the development of therapies for rare and common cancers. Its pipeline compound portfolio includes cirmtuzumab and TK216. The company’s pipeline compounds are primarily focus …
  • Consort Medical plc (CSRT):製薬・医療:M&Aディール及び事業提携情報
    Summary Consort Medical plc (Consort Medical) is a contract development and manufacturing organization (CDMO) with focus on medical device technologies for drug delivery. It develops, manufactures and markets high volume disposable medical devices for drug delivery and point-of-care (POC) diagnostic …
  • Taris Biomedical LLC:企業のM&A・事業提携・投資動向
    Taris Biomedical LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Taris Biomedical LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Oxford Immunotec Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Oxford Immunotec Ltd (Oxford Immunotec) a subsidiary of Oxford Immunotec Global Plc is a medical device company that offers proprietary tests for immune-regulated conditions. The company offers in vitro diagnostic, T-SPOT CMV Test, C6 Lyme ELISA Test, T-Cell Xtend Reagent. It offers T-SPOT.T …
  • Tikcro Technologies Ltd (TIKRF):企業の財務・戦略的SWOT分析
    Summary Tikcro Technologies Ltd (Tikcro) is a biotechnology company that discovers, develops, manufactures and markets antibodies. The company undertakes clinical trials for its pipeline products PD1, PDL1, PDL2, TIGIT and CTLA-4 products, among others. Its products are based on 3D antigens designed …
  • Bioplus Life Sciences Private Limited:企業の戦略・SWOT・財務情報
    Bioplus Life Sciences Private Limited - Strategy, SWOT and Corporate Finance Report Summary Bioplus Life Sciences Private Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Bemis Company Inc (BMS):企業の財務・戦略的SWOT分析
    Bemis Company Inc (BMS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Harbin Electric Co Ltd (1133):企業の財務・戦略的SWOT分析
    Harbin Electric Co Ltd (1133) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Avanir Pharmaceuticals Inc:企業の戦略的SWOT分析
    Avanir Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • West Japan Railway Company (9021):企業の財務・戦略的SWOT分析
    West Japan Railway Company (9021) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Covance Inc-製薬・医療分野:企業M&A・提携分析
    Summary Covance Inc (Covance), a subsidiary of LabCorp, is a drug development company that offers contract research and manufacturing services. The company offers a broad range of early-stage and late-stage product development services to pharmaceutical, biotechnology and medical device companies. I …
  • Nordson Corporation:企業の戦略・SWOT・財務情報
    Nordson Corporation - Strategy, SWOT and Corporate Finance Report Summary Nordson Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Seacor Holdings Inc (CKH):企業の財務・戦略的SWOT分析
    Summary Seacor Holdings Inc (Seacor) is a diversified holding company that offers domestic and international transportation, logistics and risk management consultancy services. The company offers ocean transportation and logistics services; inland transportation and logistics services; Witt O'Brien' …
  • Florida Power & Light Co:発電所・企業SWOT分析
    Florida Power & Light Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Medivir AB (MVIR B):企業の財務・戦略的SWOT分析
    Summary Medivir AB (Medivir) is a drug discovery and development company focusing on transformative cancer drugs. The company offers products under development for the treatment of cutaneous T-cell lymphoma, osteoarthritis, solid tumors, hepatocellular carcinoma and RSV-infection. Medivir also provi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆